Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $199,834 | $209,093 | $261,460 | $246,332 |
| - Cash | $3,669 | $5,741 | $8,496 | $20,549 |
| + Debt | $722 | $803 | $880 | $954 |
| Enterprise Value | $196,887 | $204,155 | $253,844 | $226,737 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$88 |
| % Margin | – | – | – | – |
| EBITDA | -$17,459 | -$24,733 | -$6,495 | -$44,098 |
| % Margin | – | – | – | – |
| Net Income | -$17,459 | -$11,216 | -$6,495 | -$44,617 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.226 | -0.15 | -0.08 | -0.75 |
| % Growth | -50.9% | -87.5% | 89.3% | – |
| Operating Cash Flow | -$14,477 | -$17,713 | -$16,060 | -$18,987 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$14,477 | -$17,713 | -$16,060 | -$18,987 |